Catherinepan (Talk | contribs) |
Catherinepan (Talk | contribs) |
||
Line 10: | Line 10: | ||
font-family: GeosansLight; | font-family: GeosansLight; | ||
-webkit-text-stroke: 1px; | -webkit-text-stroke: 1px; | ||
− | + | padding-left: 50px; | |
font-size: 30px; | font-size: 30px; | ||
letter-spacing: 1.5px; | letter-spacing: 1.5px; |
Revision as of 03:18, 20 August 2018
UBC iGEM 2018: Distributed Metabolic Pathway of Naringenin
Dividing metabolism amongst microbial communities has shown huge potential for the large-scale production of chemical products. Unfortunately, optimizing the population dynamics of the individual strain modules remains a challenge (Jones & Wang, 2018). Our goal is to improve the production of naringenin and its pharmaceutically significant derivatives, which have anti-cancer and anti-inflammatory properties, by distributing the synthesis of a naringenin derivative between two E. coli strains and optimizing their relative proportions in co-culture. One strain will produce naringenin from glucose and the second strain will create the naringenin derivative. We will regulate the ratio of the two strains using a biosensor and a toehold switch. This will couple cell growth with the concentration of naringenin, allowing the co-culture to self-optimize and increase naringenin production. Using our system, we will have demonstrated a novel way to optimize microbial polycultures for the synthesis of metabolically complex compounds.